4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-047613
SVP, COO & CFO sold 8,245 shares at an average $19.67 ($162,199)
From the SEC's structured data for this filing
Trades in this filing
Labrucherie Gil M · SVP, COO & CFO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-17 | Sale : show line 1 in the form | −6,245 | $19.67 | $122,839 | 239,249 | D |
| 2020-08-18 | Sale : show line 2 in the form | −2,000 | $19.68 | $39,360 | 237,249 | D |
| Open-market sales · 8,245 sh · avg $19.67 · $162,199 | ||||||
Loading xslF345X03/doc4.xml…